Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA warning letters detail issues for manufacturing sites in the US and India
3 years ago
Pharma
FDA+
Novo Nordisk drops two programs as it plots Wegovy comeback
3 years ago
Pharma
Allogene Overland Biopharm completes Shanghai facility to manufacture CAR-T products
3 years ago
Pharma
Cell/Gene Tx
CVS, Walgreens and Walmart reach nearly $12B settlement over opioid epidemic
3 years ago
Law
For months Biden has touted his win over pharma in the election lead-up. Will it help?
3 years ago
FDA+
Law
Surface Oncology lays off 20% as biotech halts CD39 work on one of its ‘crown jewels’
3 years ago
People
R&D
In spinning out cancer pipeline, Alkermes cites Inflation Reduction Act's hypothetical incentives for biologics R&D
3 years ago
Deals
R&D
Basilea’s cancer pipeline slimdown continues; Aquestive looks to outlicense seizure drug in US
3 years ago
News Briefing
Rigel churns out another late-stage clinical failure — this time in Covid-19
3 years ago
R&D
Coronavirus
An NK cell therapy biotech pulls IPO ambitions weeks after second trial clearance
3 years ago
Financing
Startups
CSL stacks up $4.5B in chips — with a $200M ante — to wager on the next-gen mRNA wave
3 years ago
Deals
ICER says it's fair for BioMarin and CSL to price incoming hemophilia gene therapies at $2M-$3M
3 years ago
Cell/Gene Tx
Updated: GSK nabs priority review on RSV vaccine, kicks off showdown with Pfizer — while 'setting the bar high' on ...
3 years ago
R&D
Pharma
CFIUS review triggers delay on F-star's sale to Chinese player
3 years ago
Deals
China
Leading a $60M launch round, RA Capital backs another 'toad venom' startup
3 years ago
Financing
Startups
Exelixis shells out $100M cash in a pair of deals, shooting for different takes on CD47, ADCs
3 years ago
Deals
Amid revenue dip, Pfizer CEO Albert Bourla is focused on 'what's next'
3 years ago
Pharma
FDA warns Amazon again for selling unapproved drugs online
3 years ago
FDA+
New JAMA study digs into the rise of stacking FDA’s expedited programs and designations for new drugs
3 years ago
FDA+
Eli Lilly plans to make tirzepatide next big thing as pharma experiences 'unprecedented' demand for the drug
3 years ago
Pharma
FDA clarifies when sponsors' expanded access policies need to be made public
3 years ago
FDA+
#CPHI22: As Samsung’s new plant comes online, it looks to expand in Korea and beyond
3 years ago
Pharma
Manufacturing
HHS renews 'call to action' with Covid booster ad spots
3 years ago
Pharma
Coronavirus
College athlete deals and pharma? Dexcom tests the waters in a first move that opens new spokesperson doors for ...
3 years ago
Pharma
Marketing
First page
Previous page
429
430
431
432
433
434
435
Next page
Last page